NCT07139457Active, not recruiting
Wearable Epileptic Seizure Prediction and Alert Glasses Based on Neuromorphic Computing
Source: ClinicalTrials.gov · Last updated 7 Oct 2025
Brief summary (registry, in English)
The NEXA study aims to evaluate a new wearable EEG device designed as smart glasses with dry electrodes positioned according to the 10-20 system. The device captures real-time brain signals to detect patterns that may predict seizures, helping people with epilepsy. This study will test the device's safety, performance, and usability before seeking regulatory approval, including FDA clearance. The NEXA device is investigational and not yet approved by the U.S. FDA. The study will involve human participants who will wear the device while data is collected and analyzed. Results will help improve the device and support future certification for medical use.
- Status (registry)
- Active, not recruiting
- Study type
- Interventional
- Enrollment
- 47 (estimated)
- First submitted
- 17 Aug 2025
- Start date
- 10 Aug 2025
- Primary completion date
- 20 Oct 2025
- Lead sponsor
- Oman Ministry of Health
- Diseases
- Epilepsy
- NCT number
- NCT07139457
What you commit to
- Study type: Interventional
- Planned participants: 47
- From 10 Aug 2025 to the primary completion date, 20 Oct 2025
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Seizures from non-epileptic causes (e.g., psychogenic, metabolic, tumors).
- Severe cognitive impairment preventing consent or protocol adherence.
- Severe uncontrolled medical conditions (e.g., heart disease, cancer).
- History of non-compliance with epilepsy treatment or follow-ups.
- Severe psychiatric disorders affecting participation or safety.
- History of substance abuse interfering with study adherence.
- Known allergies or hypersensitivity to study medications or procedures.
Age
- Under 18 years of age.
Other
- Pregnant or planning pregnancy during the study.
Who the study is looking for
- Adults (≥18 years) with a confirmed epilepsy diagnosis by a neurologist or epilepsy specialist.
- History of active seizures within the last year, under stable treatment (medications, VNS, diet, or surgery) for at least 3 months.
- Capacity to provide informed consent (or via legal representative if cognitively impaired).
- Willingness to participate and sign consent.
- Residents of Oman attending Khoula Hospital or affiliated clinics.
- Stable general health without acute or severe comorbidities.
- Ability and willingness to attend study visits and follow protocols.
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Khoula Hospital Coordinator of this site? Confirm its status | Muscat | Oman | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.